Raffaele

@DEGIRO can you add RVI (Robinhood Ventures)

Lucara diamond LVMH takeover target? DeBeers was once a partner.

@DEGIRO Is there a way to request it made available? I can buy other stocks on Nasdaq CM.

@vestenius Hello Raffaele, unfortunately, this product is not available on our platform.

@DEGIRO can I access Nasdaq CM? Specifically ticker FRGT - Freight Technologies, Inc.

Excited to have installed Illinois’ first humanoid drink robot! ADAM is officially serving coffee and tea drinks at a One Kitchen restaurant in a Rockford Walmart. Stop by for your favorite drink. #RichtechRobotics #robotichospitality

Something new is coming!!! 👀 Can you guess what? #automation #robotics #SneakPeek #new #AI

@DEGIRO why can’t I buy Lockheed Martin? LMT

All our efforts are focused on FDA approval process! We will update you soon...

Once again, Innocan has shown liposomal-CBD to be effectively active for pain relief and well-being. We see this pre-clinical treatment as strong evidence of liposomal-CBD's potential to improve the lives of animal patients and potentially human patients." youtu.be/Hgqh2WOlwJQ?si…

"We are very pleased with our performance in 2023, closing the year with a strong fourth quarter. This was due to the strong execution by our team in the quarter as well as throughout the year.” finance.yahoo.com/news/innocan-p…

New Snowflake $SNOW CEO Sridhar Ramaswamy just filed for his purchase of an additional 31,542 shares of $SNOW at an average price of $158.52 per share

Follow up meetings in NY…

1 in 5 US adults suffer from chronic pain, which is often controlled with opioids. If the FDA process confirms what the animal tests showed, Innocan may have developed an effective, less addictive alternative to opioids.

@FCKobenhavn @FCBayernEN you can’t beg for consistent handballs decisions if yesterdays @PSG_English penalty was the wrong decision

🚀Ready to Disrupt the Pharma World? We are!🌟 Our eyes are set on a $7.2B exit like GW Pharma!💰 We don't waste 'em!🕒.🔬Paving the way for FDA certification of our groundbreaking Liposome/CBD drug (LPD)! Thrilled to welcome Dr. Pergolizzi as our advisor, 📣Stay tuned! 🔥

📢 Exciting times for #InnocanPharma! We're thrilled to be featured in New York Weekly discussing our financial growth & clinical milestones for Q2 2023. nyweekly.com/health/innocan… Progress, dedication, and innovation continue to define our journey. 🚀 $INNO.CN $INNPF $IP4 $INNO #NYWeekly #FinancialGrowth

This will make everything much less complicated! Big effect for our cosmetic line and also for our epilepsy/arthritis science! . HHS Calls for Moving Marijuana to Lower-Risk US Drug Category - Bloomberg bloomberg.com/news/articles/…

"We are thrilled with the significant growth we achieved in the second quarter”. $INNO, $IP4, $INNPF finance.yahoo.com/news/innocan-p…

Thank you #MarketsHerald for sharing our great news! "Unlocking Market Potential: Innocan Pharma's Breakthrough Cream Shows Promise in Diabetic Foot Care" marketsherald.com/innocan-pharma…… $INNO.CN $INNO $INNPF $IP4 #Breakthrough #Diabetes #PharmaInnovation

9 months trading volume in one day @InnocanP @IrisBincovich